Anna Gutkin

936 total citations · 1 hit paper
11 papers, 744 citations indexed

About

Anna Gutkin is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Anna Gutkin has authored 11 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Biomedical Engineering and 2 papers in Biomaterials. Recurrent topics in Anna Gutkin's work include Extracellular vesicles in disease (4 papers), RNA Interference and Gene Delivery (4 papers) and Nanoparticle-Based Drug Delivery (2 papers). Anna Gutkin is often cited by papers focused on Extracellular vesicles in disease (4 papers), RNA Interference and Gene Delivery (4 papers) and Nanoparticle-Based Drug Delivery (2 papers). Anna Gutkin collaborates with scholars based in Israel, United States and Italy. Anna Gutkin's co-authors include Dan Peer, Zvi R. Cohen, Daniel Rosenblum, Nuphar Veiga, Srinivas Ramishetti, Judy Lieberman, Dinorah Friedmann‐Morvinski, Mark A. Behlke, Ranit Kedmi and Ashley M. Jacobi and has published in prestigious journals such as Advanced Drug Delivery Reviews, Journal of Controlled Release and Science Advances.

In The Last Decade

Anna Gutkin

11 papers receiving 737 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy

2020 430 citations Daniel Rosenblum, Anna Gutkin et al. Science Advances profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna Gutkin Israel	7	628	149	122	101	97	11	744
William Cantley United States	5	830 1.3×	165 1.1×	135 1.1×	112 1.1×	88 0.9×	7	964
Eriya Kenjo Japan	9	602 1.0×	79 0.5×	105 0.9×	215 2.1×	112 1.2×	10	812
Katrin Tiemann United States	11	702 1.1×	183 1.2×	108 0.9×	52 0.5×	64 0.7×	15	845
Mustafa M. Munye United Kingdom	14	543 0.9×	44 0.3×	196 1.6×	104 1.0×	66 0.7×	17	784
Jason G. Fewell United States	18	704 1.1×	94 0.6×	200 1.6×	56 0.6×	126 1.3×	30	1.1k
Xuewei Zhao United States	12	854 1.4×	91 0.6×	161 1.3×	79 0.8×	121 1.2×	12	1.0k
Min‐Yuan Chou Taiwan	14	878 1.4×	97 0.7×	58 0.5×	63 0.6×	55 0.6×	20	1.0k
Alireza Shahryari Iran	10	497 0.8×	245 1.6×	138 1.1×	34 0.3×	57 0.6×	21	674
Wenxin Cai China	6	773 1.2×	177 1.2×	168 1.4×	36 0.4×	57 0.6×	9	950
Kristi D. Viles United States	8	970 1.5×	168 1.1×	101 0.8×	61 0.6×	87 0.9×	12	1.1k

Countries citing papers authored by Anna Gutkin

Since Specialization

Citations

This map shows the geographic impact of Anna Gutkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Gutkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Gutkin more than expected).

Fields of papers citing papers by Anna Gutkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Gutkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Gutkin. The network helps show where Anna Gutkin may publish in the future.

Co-authorship network of co-authors of Anna Gutkin

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Gutkin. A scholar is included among the top collaborators of Anna Gutkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Gutkin. Anna Gutkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Ad‐El, Nitay, Meir Goldsmith, Anna Gutkin, et al.. (2025). Low-frequency ultrasound-mediated blood-brain barrier opening enables non-invasive lipid nanoparticle RNA delivery to glioblastoma. Journal of Controlled Release. 385. 114018–114018. 4 indexed citations

2.

Rotem, Ofer, Alona Zer, Einat Beery, et al.. (2023). Blood-Derived Exosomal hTERT mRNA in Patients with Lung Cancer: Characterization and Correlation with Response to Therapy. Biomedicines. 11(6). 1730–1730. 3 indexed citations

3.

Goldsmith, Meir, Srinivas Ramishetti, Nuphar Veiga, et al.. (2021). Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticles. Journal of Controlled Release. 337. 378–389. 41 indexed citations

4.

Rosenblum, Daniel, Anna Gutkin, Ranit Kedmi, et al.. (2020). CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy. Science Advances. 6(47). 430 indexed citations breakdown →

5.

Rosenblum, Daniel, Anna Gutkin, Niels Dammes, & Dan Peer. (2020). Progress and challenges towards CRISPR/Cas clinical translation. Advanced Drug Delivery Reviews. 154-155. 176–186. 46 indexed citations

6.

Mizrahy, Shoshy, Anna Gutkin, Paolo Decuzzi, & Dan Peer. (2018). Targeting central nervous system pathologies with nanomedicines. Journal of drug targeting. 27(5-6). 542–554. 16 indexed citations

7.

Goldvaser, Hadar, Anna Gutkin, Einat Beery, et al.. (2017). Characterisation of blood-derived exosomal hTERT mRNA secretion in cancer patients: a potential pan-cancer marker. British Journal of Cancer. 117(3). 353–357. 48 indexed citations

8.

Gutkin, Anna, Dan Peer, & Zvi R. Cohen. (2017). DDIS-03. HARNESSING siRNA NANOMEDICINE FOR THERAPEUTIC GENE SILENCING IN GLIOBLASTOMA. Neuro-Oncology. 19(suppl_6). vi59–vi59. 1 indexed citations

9.

Uziel, Orit, Anna Gutkin, Einat Beery, & Meir Lahav. (2017). [EXOSOMES AS MEDIATORS OF INTERCELLULAR COMMUNICATION: THE CANCER AND TELOMERASE CONNECTION].. PubMed. 156(11). 710–714. 3 indexed citations

10.

Gutkin, Anna, Orit Uziel, Einat Beery, et al.. (2016). Tumor cells derived exosomes contain hTERT mRNA and transform nonmalignant fibroblasts into telomerase positive cells. Oncotarget. 7(37). 59173–59188. 104 indexed citations

11.

Gutkin, Anna, Zvi R. Cohen, & Dan Peer. (2016). Harnessing nanomedicine for therapeutic intervention in glioblastoma. Expert Opinion on Drug Delivery. 13(11). 1573–1582. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact